Clinical Evaluation of the Use of Exemestane as Further Hormonal Therapy after Nonsteroidal Aromatase Inhibitors in Postmenopausal Metastatic Breast Cancer Patients

By Carlini Paolo   Michelotti Andrea   Ferretti Gianluigi   Ricci Sergio   Giannarelli Diana   Pellegrini Manuela   Cresti Nicola   Cosimo Serena Di   Bria Emilio   Papaldo Paola   Fabi Alessandra   Ruggeri Enzo Maria   Milella Michele   Alimonti Andrea   Salesi Nello   Cognetti Francesco  

Cancer Investigation, Vol. 25, Iss. 2, 2007-03 ,pp. : 102-105

Informa Healthcare

Access to resources Recommend Favorite

Comparing the outcome between multicentric and multifocal breast cancer: what is the impact on survival, and is there a role for guideline-adherent adjuvant therapy? A retrospective multicenter cohort study of 8,935 patients

By Wolters R.   Wöckel A.   Janni W.   Novopashenny I.   Ebner F.   Kreienberg R.   Wischnewsky M.   Schwentner L.  

Breast Cancer Research and Treatment, Vol. 142, Iss. 3, 2013-12 ,pp. : 579-590

Springer Publishing Company

Access to resources Recommend Favorite

Hormonal therapy for postmenopausal breast cancer: the science of sequencing

By Miller William   Bartlett John   Canney Peter   Verrill Mark  

Breast Cancer Research and Treatment, Vol. 103, Iss. 2, 2007-06 ,pp. : 149-160

Springer Publishing Company

Access to resources Recommend Favorite

Adverse events and bone health during anastrozole therapy in postmenopausal Japanese breast cancer patients

By Sagara Yasuaki  

Breast Cancer, Vol. 17, Iss. 3, 2010-07 ,pp. : 212-217

Springer Publishing Company

Access to resources Recommend Favorite

Dose-dependent effect of tamoxifen therapy on endometrial pathologies in postmenopausal breast cancer patients

By Cohen I.  

Breast Cancer Research and Treatment, Vol. 53, Iss. 3, 1999-02 ,pp. : 255-262

Springer Publishing Company

Access to resources Recommend Favorite